The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hospitalization burden and end-of-life (EOL) care in elderly patients with glioblastoma (GBM).
 
Laura Donovan
No Relationships to Disclose
 
Donna Buono
No Relationships to Disclose
 
Melissa Kate Accordino
Honoraria - Charter Oak Research; Deerfield Management; Enterprise Analysis Corporation; ExpertConnect; Incrowd; M3; M3 (I); Massive Bio; MDoutlook; Medpanel; Medscape; Medscape; medsurvey; OCN; Sermo; Sermo (I)
Other Relationship - Onclive
 
Jason Dennis Wright
Consulting or Advisory Role - Clovis Oncology
Research Funding - Merck (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Andrew B. Lassman
Honoraria - Abbott Molecular
Consulting or Advisory Role - Bayer; BioClinica; Elsevier; FORMA Therapeutics; Karyopharm Therapeutics; Novocure; Orbus Therapeutics; QED Therapeutics; Sapience Therapeutics
Research Funding - Abbvie (Inst); Aeterna Zentaris (Inst); Agios (Inst); Bayer (Inst); BeiGene (Inst); BMS (Inst); Celldex (Inst); Genentech/Roche (Inst); Kadmon (Inst); Karyopharm Therapeutics (Inst); Millennium (Inst); Novartis (Inst); Oncoceutics (Inst); Orbus Therapeutics (Inst); Pfizer (Inst); QED Therapeutics (Inst); RTOG Foundation (Inst); VBI Vaccines (Inst)
Patents, Royalties, Other Intellectual Property - Elsevier
Travel, Accommodations, Expenses - Abbott Molecular; AbbVie; Bayer; BioClinica; FORMA Therapeutics; Karyopharm Therapeutics; Novartis; Orbus Therapeutics; Pfizer; QED Therapeutics
 
Dawn L. Hershman
Consulting or Advisory Role - AIM Specialty Health